These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37997483)

  • 21. Clinical manifestation of patients with isolated rapid eye movement sleep behavior disorder after modest-to-long disease duration.
    Hong JK; Kim JM; Kim KW; Han JW; Ahn S; Yoon IY
    Sleep; 2022 Jun; 45(6):. PubMed ID: 35325247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fate of patients with REM sleep behavior disorder and mild cognitive impairment.
    Arnaldi D; Chincarini A; De Carli F; Famà F; Girtler N; Brugnolo A; Pardini M; Massa F; Meli R; Schenone C; Bauckneht M; Morbelli S; Nobili F
    Sleep Med; 2021 Mar; 79():205-210. PubMed ID: 32451160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tonic REM sleep muscle activity is the strongest predictor of phenoconversion risk to neurodegenerative disease in isolated REM sleep behaviour disorder.
    Singh A; Williams S; Calabrese A; Riha R
    J Sleep Res; 2023 Jun; 32(3):e13792. PubMed ID: 36451603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.
    Fereshtehnejad SM; Yao C; Pelletier A; Montplaisir JY; Gagnon JF; Postuma RB
    Brain; 2019 Jul; 142(7):2051-2067. PubMed ID: 31111143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated rapid eye movement sleep behavior disorder and cyclic alternating pattern: is sleep microstructure a predictive parameter of neurodegeneration?
    Melpignano A; Parrino L; Santamaria J; Gaig C; Trippi I; Serradell M; Mutti C; Riccò M; Iranzo A
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31323084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk?
    Arnaldi D; Antelmi E; St Louis EK; Postuma RB; Arnulf I
    Sleep Med Rev; 2017 Dec; 36():82-95. PubMed ID: 28082168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma immune markers in an idiopathic REM sleep behavior disorder cohort.
    Zhang H; Wang T; Li Y; Mao W; Hao S; Huang Z; Chan P; Cai Y
    Parkinsonism Relat Disord; 2020 Sep; 78():145-150. PubMed ID: 32835920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
    Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive and motor profiles as prodromal markers in predicting phenoconversion and phenotype in isolated REM sleep behavior disorder.
    Zhang X; Liang D; Ma L; Huang Y; Wan Y; Zhou K; Xu L; Wu W; Xue R; Zhang N
    Sleep Med; 2023 Dec; 112():262-272. PubMed ID: 37925853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder.
    Yoon EJ; Lee JY; Kim H; Yoo D; Shin JH; Nam H; Jeon B; Kim YK
    Neurology; 2022 Jun; 98(24):e2413-e2424. PubMed ID: 35437260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort.
    Orso B; Mattioli P; Yoon EJ; Kim YK; Kim H; Shin JH; Kim R; Liguori C; Famà F; Donniaquio A; Massa F; García DV; Meles SK; Leenders KL; Chiaravalloti A; Pardini M; Bauckneht M; Morbelli S; Nobili F; Lee JY; Arnaldi D
    Neurol Sci; 2023 Sep; 44(9):3161-3168. PubMed ID: 37140829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions.
    Iranzo A; Santamaria J; Tolosa E
    Lancet Neurol; 2016 Apr; 15(4):405-19. PubMed ID: 26971662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
    Schenck CH; Montplaisir JY; Frauscher B; Hogl B; Gagnon JF; Postuma R; Sonka K; Jennum P; Partinen M; Arnulf I; Cochen de Cock V; Dauvilliers Y; Luppi PH; Heidbreder A; Mayer G; Sixel-Döring F; Trenkwalder C; Unger M; Young P; Wing YK; Ferini-Strambi L; Ferri R; Plazzi G; Zucconi M; Inoue Y; Iranzo A; Santamaria J; Bassetti C; Möller JC; Boeve BF; Lai YY; Pavlova M; Saper C; Schmidt P; Siegel JM; Singer C; St Louis E; Videnovic A; Oertel W
    Sleep Med; 2013 Aug; 14(8):795-806. PubMed ID: 23886593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy.
    Arnaldi D; Mattioli P; Famà F; Girtler N; Brugnolo A; Pardini M; Donniaquio A; Massa F; Orso B; Raffa S; Bauckneht M; Morbelli S; Nobili F
    Mov Disord; 2022 Jan; 37(1):52-61. PubMed ID: 34533239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous tonic and phasic REM sleep without atonia best predicts early phenoconversion to neurodegenerative disease in idiopathic REM sleep behavior disorder.
    Nepozitek J; Dostalova S; Dusek P; Kemlink D; Prihodova I; Ibarburu Lorenzo Y Losada V; Friedrich L; Bezdicek O; Nikolai T; Perinova P; Dall'Antonia I; Dusek P; Ruml M; Ruzicka E; Sonka K
    Sleep; 2019 Sep; 42(9):. PubMed ID: 31194249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electromyography activity level in rapid eye movement sleep predicts neurodegenerative diseases in idiopathic rapid eye movement sleep behavior disorder: a 5-year longitudinal study.
    Liu Y; Zhang J; Lam SP; Yu MWM; Li SX; Zhou J; Chan NY; Wang J; Feng H; Chan A; Mok V; Wing YK
    Sleep Med; 2019 Apr; 56():128-134. PubMed ID: 30852128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Transferrin Sialylation Predicts Phenoconversion in Isolated REM Sleep Behavior Disorder.
    Ganapathy S R; Levová K; Kotačková L; Trnka J; Zogala D; Rusz J; Zima T; Devos D; Šonka K; Růžička E; Kalousová M; Dušek P
    Mov Disord; 2022 May; 37(5):983-992. PubMed ID: 35128728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study.
    Postuma RB; Iranzo A; Hogl B; Arnulf I; Ferini-Strambi L; Manni R; Miyamoto T; Oertel W; Dauvilliers Y; Ju YE; Puligheddu M; Sonka K; Pelletier A; Santamaria J; Frauscher B; Leu-Semenescu S; Zucconi M; Terzaghi M; Miyamoto M; Unger MM; Carlander B; Fantini ML; Montplaisir JY
    Ann Neurol; 2015 May; 77(5):830-9. PubMed ID: 25767079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients.
    Fernández-Arcos A; Iranzo A; Serradell M; Gaig C; Santamaria J
    Sleep; 2016 Jan; 39(1):121-32. PubMed ID: 26940460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.